Fact Sheet – Trichothecene Mycotoxin (T2)

Loading...

DSHS Fact Sheet header

Agent: Trichothecene mycotoxin (T2) can theoretically be used in aerosol form (yellow rain) to produce lethal and nonlethal casualties. T2 is one of the more stable toxins, retaining its bioactivity even when heated to very high temperatures. T2 can enter the body through the skin and aerodigestive epithelium, without being inhaled, and quickly inhibit protein and nucleic acid synthesis.

Disease: T2 mycotoxin intoxification

Time to Onset: Minutes to hours

Signs/Symptoms: T2 exposure causes pruritis, redness, vessicles, necrosis, epidermal sloughing, dysesthesias(distortion of any of the senses), nausea, weight loss, vomiting and diarrhea. Effects on the airway include nose and throat pain, nasal discharge, itching and sneezing, cough, dyspnea, wheezing, chest pain and hemoptysis. T2 also produces effects after ingestion or eye contact. Severe poisoning results in prostration, weakness, ataxia, collapse, reduced cardiac output, shock, and death.

Diagnosis:
Differential Diagnosis: Mycotoxin intoxification should be considered especially when multiple patients present with similar clinical syndromes, particularly if victims report a "yellow rain" or if droplets of yellow fluid contaminate clothing or the environment. Radiation, chemical, or plant toxicity are other diagnoses to consider.

Diagnostic Tests: Gas-liquid chromatography (GLC) and high pressure liquid chromatography (HPLC) with mass spectrometry (MS) may be used to detect T2 and related tricothecene mycotoxins in plasma and urine. Between 50-75% of the toxin and metabolites are eliminated in the urine and feces within 24 hours. Toxin metabolites may be detected up to 28 days after exposure.

Early postexposure (0-24 hours) nasal or throat swabs and induced respiratory secretions may be collected for HPLC/GLC/MS and immunoassay. During the clinical phase (24 - 72 hours) blood for serum may be collected in a tiger-top (SST) or red top tube for toxin assays. Urine may be collected with 0.1ml concentrated hydrochloric acid (HCl) added per 100 ml of urine for recent exposure. If several days have elapsed since exposure, a 24-hour urine collection with HCl added should be submitted.

Send specimens in a triple container along with the General Submission Form (contact (512) 458-7598 to order) (G-1A for bacterial/virologic cultures, G-1B for serologic tests) to the Texas Department of State Health Services Laboratory, 1100 West 49th Street, Austin, TX 78756.

Supportive Tests: In the rodent model, hematological alterations include marked but transient leukocytosis characterized by rapid lymphocytosis and a mild neutrophilia. Leukopenia that returns to normal values 4-7 days postexposure follows. There is also a reduced hematocrit with the presence of nucleated erythrocytes.

Treatment: Outer clothing should be removed and exposed skin should be decontaminated with soap and water. Superactivated charcoal should be given orally if toxin is swallowed. Eye exposure should be treated with copious saline irrigation. Supportive therapy should be provided as needed.

Exposure Control/Decontamination: Standard precautions should be practiced. A chemical protective mask and clothing are required to avoid exposure. Exposed skin should be washed with soap and water. Bed linens, clothing, other exposed articles, and wash waste can be decontaminated through the use of a hypochlorite solution under alkaline conditions such as 1% sodium hypochlorite and 0.1M NaOH with one hour contact time.

Report: Any suspect cases should be reported immediately to the local health authorities (1-800-705-8868) and Poison Control at 1-800-764-7661.

 

Note: External links to other sites are intended to be informational and do not have the endorsement of the Texas Department of State Health Services. These sites may also not be accessible to people with disabilities.

Last updated March 16, 2012